Based on this study, the authors suggested that cortisol might be one of the regulators implicated in AD pathogenesis, controlling the secretion of interleukin (IL) 4 and IL-5, which are the stimulating factors in the early stage of AD by activating Th-2 (Liu et al., 2011). The gene discussed is IL5; the disease is Alzheimer disease.